Literature DB >> 30601489

A novel tumor and mitochondria dual-targeted photosensitizer showing ultra-efficient photodynamic anticancer activities.

Xuan Zhao1, Yuchao Huang, Gankun Yuan, Ke Zuo, Yafan Huang, Juanjuan Chen, Jinyu Li, Jinping Xue.   

Abstract

We designed and synthesized a simple, but highly effective photosensitizer (G-Mito-Pc), which can precisely target the mitochondria of epidermal growth factor receptor (EGFR)-overexpressing cancer cells, to achieve dual targeting function at both cell and organelle levels in cancer therapy. We further explored the possible molecular mechanism of the enhanced bioactivity of G-Mito-Pc compared to that of the reference photosensitizer using molecular dynamics simulations on their interactions with a physiologically relevant mitochondrial membrane model.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30601489     DOI: 10.1039/c8cc09456j

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  4 in total

Review 1.  TPP-based mitocans: a potent strategy for anticancer drug design.

Authors:  Jiayao Wang; Jiaqi Li; Yumei Xiao; Bin Fu; Zhaohai Qin
Journal:  RSC Med Chem       Date:  2020-06-03

2.  p-Pyridinyl oxime carbamates: synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies.

Authors:  Panagiotis S Gritzapis; Panayiotis C Varras; Nikolaos-Panagiotis Andreou; Katerina R Katsani; Konstantinos Dafnopoulos; George Psomas; Zisis V Peitsinis; Alexandros E Koumbis; Konstantina C Fylaktakidou
Journal:  Beilstein J Org Chem       Date:  2020-03-09       Impact factor: 2.883

Review 3.  EGFR-Targeted Photodynamic Therapy.

Authors:  Luca Ulfo; Paolo Emidio Costantini; Matteo Di Giosia; Alberto Danielli; Matteo Calvaresi
Journal:  Pharmaceutics       Date:  2022-01-20       Impact factor: 6.321

4.  Bromopropylate Imidazoliumyl Substituted Silicon Phthalocyanine for Mitochondria-Targeting, Two-Photon Imaging Guided in Vitro Photodynamic Therapy.

Authors:  Kuizhi Chen; Jialin Hou; Bingcheng Huang; Shuanghuang Xiao; Xia Li; Hong Sun; Yiru Peng
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.